Logo Logo
Group by: Item Type | Date
Number of items: 11.

Journal article

Krug, U.; Berdel, W. E.; Gale, R. P.; Haferlach, C.; Schnittger, S.; Müller-Tidow, C.; Braess, J.; Spiekermann, K.; Staib, P.; Beelen, D.; Serve, H.; Schliemann, C.; Stelljes, M.; Balleisen, L.; Maschmeyer, G.; Grüneisen, A.; Eimermacher, H.; Giagounidis, A.; Rasche, H.; Hehlmann, R.; Lengfelder, E.; Thiel, E.; Reichle, A.; Aul, C.; Ludwig, W.-D.; Kern, W.; Haferlach, T.; Köpcke, W.; Görlich, D.; Sauerland, M. C.; Heinecke, A.; Wörmann, B. J.; Hiddemann, W. und Büchner, T. (2016): Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia. In: Leukemia, Vol. 30, No. 6: pp. 1230-1236

Bellos, F.; Sotlar, K.; Jeromin, S.; Haferlach, C.; Haferlach, T. und Kern, W. (2016): Assessment of CD30 expression on mast cells in systemic mastocytosis by immunohistochemistry versus multiparameter flow cytometry and correlation to clinical parameters. In: Oncology Research and Treatment, Vol. 39: p. 152

Schmidt, Heinrich; Giese, Renate; Enders, Angelika; Kern, W. und Hallschmid, M. (2009): Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial. In: Journal of Medical Genetics, Vol. 46: pp. 217-222 [PDF, 584kB]

Schoch, C.; Kohlmann, A.; Dugas, Martin; Kern, W.; Hiddemann, Wolfgang; Schnittger, S. und Haferlach, T. (2005): Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q. In: Leukemia, Vol. 19, No. 7: pp. 1224-1228

Kohlmann, A.; Schoch, C.; Dugas, Martin; Rauhut, S.; Weninger, F.; Schnittger, S.; Kern, W. und Haferlach, T. (2005): Pattern robustness of diagnostic gene expression signatures in leukemia. In: Genes, Chromosomes and Cancer, Vol. 42, No. 3: pp. 299-307

Kohlmann, A.; Schoch, C.; Dugas, Martin; Schnittger, S.; Hiddemann, Wolfgang; Kern, W. und Haferlach, T. (2005): New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes. In: Leukemia, Vol. 19, No. 6: pp. 953-964

Haferlach, T.; Kohlmann, A.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Schoch, C. (2005): AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes. In: Genes, Chromosomes and Cancer, Vol. 43, No. 2: pp. 113-127

Haferlach, T.; Kohlmann, A.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Schoch, C. (2005): Global approach to the diagnosis of leukemia using gene expression profiling. In: Blood, Vol. 106, No. 4: pp. 1189-1198

Kohlmann, A.; Schoch, C.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Haferlach, T. (2004): Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients. In: Leukemia, Vol. 18, No. 1: pp. 63-71

Schoch, C.; Schnittger, S.; Kern, W.; Dugas, Martin; Hiddemann, Wolfgang und Haferlach, T. (2003): Acute myeloid leukemia with recurring chromosome abnormalities as defined by the WHO-classification: incidence of subgroups, additional genetic abnormalities, FAB subtypes and age distribution in an unselected series of 1,897 patients with acute myeloid leukemia. In: Haematologica, Vol. 88, No. 3: pp. 351-352

Kohlmann, A.; Schoch, C.; Schnittger, S.; Dugas, Martin; Hiddemann, Wolfgang; Kern, W. und Haferlach, T. (2003): Molecular characterization of acute leukemias by use of microarray technology. In: Genes, Chromosomes and Cancer, Vol. 37, No. 4: pp. 396-405

This list was generated on Sun Dec 1 05:41:15 2024 CET.